Xinguang Pharmaceutical: Shareholders holding more than 5% of the shares reduce their holdings by 1.34%.

Xinguang Pharmaceutical announced that shareholder Shengzhou Hefeng Investment Co., Ltd., holding more than 5% of the company's shares, reduced its holdings by 2.137 million shares through block trades from June 5th to 12th, 2026, accounting for 1.3356% of the total share capital. Before the reduction, Hefeng Investment held 14.9999% of the shares; after the reduction, it held 13.6643%, with the change in shareholding exceeding a multiple of 1%. This reduction is in line with the disclosed reduction plan, and will not affect the company's governance structure and ongoing operations, nor will it result in a change of control.